Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody Development

Title
Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody Development
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 14, Issue 23, Pages 7624-7634
Publisher
American Association for Cancer Research (AACR)
Online
2008-12-01
DOI
10.1158/1078-0432.ccr-08-1547

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started